Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
•
Neuro-critical care
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
Related Questions
Which factors help you choose between intermittent phenobarbital dosing versus continuous pentobarbital infusion for pharmacological burst suppression in refractory status epilepticus?
How do you approach tapering high dose continuous infusions for status epilepticus in patients experiencing serious medication-related toxicity?
What markers on EEG can help predict/detect postoperative or ICU-related delirium?
When do you consider switching a generic formulation antiseizure medication to the brand formulation?
What MRI findings would you consider compatible with an acute seizure or seizures?
How do you determine when patients can resume their previous activities after a subdural hemorrhage?
When do you consider cannabidiol for treatment of epilepsy?
How do you advise patients with epilepsy that are planning pregnancy and use invasive neuromodulation for treatment of their epilepsy?
How do you discontinue ketogenic diets previously used as a treatment for epilepsy?
Among patients with secured subarachnoid hemorrhage who are receiving daily TCDs, what is the appropriate frequency of post operative neurological assessments?
